Lithium Carbonate Tablet, Extended Release
Product Images NDC 64980-205

1 FDA label image from Rising Pharma Holdings, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 64980-205). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Lithium Carbonate Er Tab 300mg 500ct

Lithium Carbonate Er Tab 300mg 500ct
Label for Lithium Carbonate Extended-Release Tablets USP, 300 mg, oral dosage form. The container holds 500 film-coated tablets. Labeled by Rising Pharma Holdings, Inc. Dosage meets USP Drug Release Test 1. Includes storage instructions and child-resistant container warning. Barcode and manufacturing details from Mumbai, India are shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.